Disclaimer: You are now leaving www.beiresources.org and are going to a website that is not operated by BEI Resources. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE: BEI Resources offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the BEI Resources website and will be redirected to another site. These sites are not under the control of BEI Resources. BEI Resources is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Please read third party privacy and security policies closely as these may be different than BEI Resources policies. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
At BEI Resources, we're the leading source for high quality cultures and reagents for microbiology and infectious diseases research. As you explore the benefits we offer, you will see how BEI Resources can serve as a catalyst for your research efforts worldwide. BEI Resources materials are provided at no cost to registered researchers (additional shipping charges may apply).
We'll take care of the details - so you can focus on your research.
Click here for available products, information and FAQs regarding the SARS-CoV-2. For any questions regarding BEI Resources and SARS-CoV-2 materials, please contact contact@beiresources.org.
The NIAID Data Ecosystem Discovery Portal (https://data.niaid.nih.gov/) allows researchers to search simultaneously across millions of publicly available datasets to find infectious and immune-mediated disease data for reanalysis and accelerates the work of researchers, leading to faster development of diagnostics, therapeutics, and vaccines.
The Discovery Portal can be used to:
Now available Mpox virus, isolate hMPXV/USA/MA001/2022 (NR-58622), from the current outbreak. For a complete listing of available of Mpox reagents and other Orthopox virus related reagents, click here.
BEI Resources is celebrating its 20th year providing unique reagents supporting infectious disease research to the global scientific community!
Vector-borne microbial pathogens have evolved a series of strategies to evade the immune system and establish infections in the mammalian host. In this setting, BEI Resources functions as a centralized bioresource for accessibility of reference strains of arthropod vectors to the global public health scientific community. The BEI Vector Resources program currently provides over 60 colonies of live mosquitoes as well as Ixodid and soft ticks, sandflies, black flies and triatomines.
The BEI Resources catalog contains more than 380 SARS-CoV-2 isolates and unique reagents representing ten Variants Being Monitored and the Variant of Concern Omicron. Recent additions include monoclonal antibodies to SARS-CoV-2 Spike glycoprotein receptor binding domain (RBD) and an isolate of lineage BA.5, now the dominant lineage in the United States...more.
A panel of monoclonal antibodies against a purified, recombinant, full-length trimeric and stabilized version of recombinant S glycoprotein protein (190 kDa), expressed in Expi293F cells, is now available.
The K. pneumoniae MRSN diversity panel is available as individual isolates (BEI Resources NR-55504 through NR-55603) and the complete panel of all 100 isolates (NR-55604). MRSN Diversity Panels are also available in the BEI Resources catalog for Acinetobacter baumannii and Pseudomonas aeruginosa.
Access to priority pathogens is critical to the research and development of novel diagnostics and antibiotics and optimization of current therapies to address increasing rates of antibacterial resistance. BEI Resources supports these efforts through the availability of top pathogens assembled into the Global Priority Superbugs collection.
As part of BEI Resources’ Enhanced Authentication Initiative, single parasite lineages were cloned from three isolates confirmed to harbor multiple parasite lineages....more.
In support of Enterovirus-D68 (EV-D68) vaccine development research, BEI Resources has performed initial screening of cell lines amenable for human vaccine development. Click here for more information.
BEI Resources is continually building a comprehensive repository of microbiological and emerging disease related organisms and reagents. Suggestions for materials to be added to our repository are always welcome. Click here to tell us what you don't see in our catalog!
Human immunodeficiency virus type 1 (HIV-1) must hijack host cellular machinery to establish infection successfully. These host proteins, known as dependency factors, play roles in every stage of the HIV-1 life cycle. The HIV Dependency CRISPR Guide Library, now available from BEI Resources as HRP-20293, was constructed to identify these HIV dependency factors.
Babesia duncani has emerged as an interesting apicomplexan parasite and a possible model to study intraerythrocytic parasitism. This parasite is closely related to Babesia microti, the main causative agent of human babesiosis, as well as Plasmodium falciparum, the causative agent of human malaria.
Rapid diagnostic tests (RDTs) based on the histidine-rich proteins 2 and 3 (HRP2 and HRP3) of the malaria parasite play a vital role in malaria diagnosis and have replaced microscopy as the laboratory confirmatory tool for clinical diagnosis in most malaria-endemic countries. However, natural deletions of hrp2 and hrp3 genes encoding these proteins can undermine the practical utility of current RDTs, which cannot detect HRP-deleted parasites, leading to false negatives.
A multi-state outbreak of Highly Pathogenic Avian Influenza (HPAI) A(H5N1) bird flu in dairy cows was initially reported on March 25, 2024. This marks the first time that these avian influenza viruses have been detected in cattle.
BEI Resources acquires, authenticates, produces and distributes a variety of materials within several biosafety levels and classifications. We understand that some researchers may only choose to order non-infectious research grade reagents through BEI Resources.
The Knowledge Base is an informational database assembled by our Support Specialists and Scientific Staff which provides additional knowledge about the BEI Resources program and reagents through questions and answers.
Sign up to receive catalog information, updates, and other technical information from BEI. BEI takes the privacy of your information very seriously.
If you have Comments, Questions and Suggestions regarding BEI Resources please contact us.